ROSEN, SKILLED INVESTOR COUNSEL, Encourages Centene Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Centene Corporation (NYSE: CNC) between December 12, 2024 and June 30, 2025, both dates inclusive (the 'Class Period'), of the important September 8, 2025 lead plaintiff deadline.
SO WHAT: If you purchased Centene securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Centene class action, go to https://rosenlegal.com/submit-form/?case_id=41552 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 8, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period provided investors with material information concerning Centene's expected revenue guidance and adjusted diluted earnings per share ('EPS') for the 2025 fiscal year. Defendants' statements included, among other things, confidence in Centene's enrollment and morbidity rates, as well as strong retention rates in Centene's Medicare business. Defendants provided these overwhelmingly positive statements to investors while simultaneously disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Centene's enrollment and morbidity rates. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Centene class action, go to https://rosenlegal.com/submit-form/?case_id=41552 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
——————————-
Contact Information:
Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827
[email protected]
www.rosenlegal.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a minute ago
- Yahoo
HIMS: Hims & Hers Shares Sink After FTC Probe Details Emerge
Aug 15 - Hims & Hers Health (NYSE:HIMS) slipped about 3% in early trading on Friday after Bloomberg published fresh details about a Federal Trade Commission probe into the company's business practices. The report says the FTC opened an inquiry following consumer complaints that Hims & Hers makes it hard for customers to cancel subscriptions and questions the company's advertising practices. Warning! GuruFocus has detected 4 Warning Sign with HIMS. Hims & Hers first told investors about a regulatory review in July 2024, but Bloomberg's report adds new color on what regulators are investigating. According to people familiar with the matter, the agency looks at cancellation flows, disclosure language, and whether marketing crosses legal lines. The company hasn't released a new statement tied to the Bloomberg story. For investors, the short-term hit reflects the subscription model's vulnerability: when regulators probe cancellation or billing, churn can rise and trust can fall. Analysts will watch complaint volumes, any formal FTC subpoenas, and whether the firm needs to change its renewal mechanics or face penalties. Until that clarity arrives, expect volatility around HIMS shares as traders price regulatory risk into the stock. Based on the one year price targets offered by 13 analysts, the average target price for Hims & Hers Health Inc is $51.22 with a high estimate of $85.00 and a low estimate of $28.00. The average target implies a upside of +8.67% from the current price of $47.13. Based on GuruFocus estimates, the estimated GF Value for Hims & Hers Health Inc in one year is $36.25, suggesting a downside of -23.09% from the current price of $47.13. Gf value is Gurufocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. For deeper insights, visit the forecast page. This article first appeared on GuruFocus. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
a minute ago
- Yahoo
Philippe Laffont Loads Up on Oracle, ARM--Cuts AMD, Alibaba, Eli Lilly Stakes
Aug 15 - Philippe Laffont (Trades, Portfolio)'s Coatue shook up its Q2 portfolio, loading into Oracle (ORCL) and ARM (NASDAQ:ARM) while exiting Super Micro (NASDAQ:SMCI) and Monolithic Power (MPWR). The firm bought roughly 3.86 million Oracle shares (about $843.3M) and 4.63 million ARM shares ($749.4M), according to its latest 13F filing, signaling renewed conviction in large-cap cloud and chip plays. Warning! GuruFocus has detected 3 Warning Sign with SMCI. Coatue also increased its stake in CoreWeave (NASDAQ:CRWV) to about 17.8M shares (~$2.9B) and added to positions in Broadcom (AVG) and Nvidia (NASDAQ:NVDA), reflecting a clear tilt toward AI infrastructure. At the same time the hedge fund trimmed holdings in Alibaba (NYSE:BABA), AMD (NASDAQ:AMD) and Eli Lilly (NYSE:LLY), and sold out of Monolithic Power and Super Micro. The moves indicate a change in strategy: strengthen names sensitive to AI compute and cloud capacity and reduce cyclical or less strategic exposure. For investors, the swaps of Coatue are of importance since their bet of more than $0.8B on Oracle reflects its conviction on cloud and software momentum. See what happens to the rest of the large funds; action across the AI related names can exaggerate moves, either upwards when new demand shines through or down when the mood swings. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Insider
3 minutes ago
- Business Insider
South Africa counters U.S. trade pressure with new trade deal with China
South Africa, long regarded as the continent's most advanced economy, is moving decisively to counter the fallout from Washington's latest tariff measures by turning to Beijing for new trade opportunities. South Africa is seeking new trade opportunities in China following recent US tariffs. A preliminary trade agreement with China focuses on the export of five types of stone fruit. This development signifies a strategic shift by South Africa to diversify its trade partnerships. The shift follows the United States' imposition of a 30% tariff on South African goods—a blow that has heightened the urgency for Pretoria to diversify its export destinations. Agriculture Minister, John Steenhuisen revealed this week that a new trade deal with China is close to completion, offering South Africa a valuable lifeline at a time of mounting trade tensions with its biggest Western partner. The agreement, which will initially cover the export of five varieties of stone fruit, is expected to open a lucrative channel into the Chinese market, one of the fastest-growing consumer bases in the world. The talks were facilitated during Steenhuisen's recent visit to Beijing alongside Deputy President Paul Mashatile. Speaking on his X page, Steenhuisen said, 'I can today share that after the last visit that I attended with the Deputy President in China, and our visit as the Agriculture Minister to the GACC, we were given the protocol for stone fruit.' He added that, 'The deal includes five types of stone fruit, which include plums, peaches, nectarines, apricots, and prunes—paving the way for stone fruit from South Africa to China.' By securing access to China's vast agricultural import market, the government aims not only to cushion the impact of US tariffs but also to strengthen South Africa's foothold in Asia's broader economic sphere. South Africa's pivot from the US amid Trump's tariff war This development marks a significant moment in South Africa's ongoing efforts to recalibrate its trade alliances, balancing long-standing relationships with the West against the rising economic pull of the East. For decades, Pretoria maintained strong commercial ties with the United States, leveraging preferential access through agreements such as AGOA to bolster its exports. However, President Donald Trump's decision to impose sweeping 30% tariffs on South African goods has accelerated the country's search for alternative markets, pushing it to engage more deeply with emerging economic powerhouses. South Africa's temperate climate and fertile valleys make it a major supplier of counter-seasonal fruit to the Northern Hemisphere. As the world's second-largest citrus exporter after Spain, South Africa also ships large volumes of apples, pears, grapes, and growing amounts of stonefruit, avocados, and blueberries. In 2024, fresh fruit exports rose 2.1% to 4.2mn tonnes, continuing a decade-long growth trend of 3.7% annually. By edging closer to a comprehensive trade agreement with China, South Africa is positioning itself to tap into one of the world's largest and fastest-growing consumer markets. The draft protocol, which initially covers the export of five varieties of stone fruit, could serve as a springboard for broader agricultural and industrial trade, potentially expanding into minerals, manufactured goods, and value-added products.
